SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Hims & Hers Sees Potential to Sell Unapproved Peptides

Hims & Hers is optimistic about the possibility of selling unapproved peptides.

HIMS